H
Henrik Ravn
Researcher at Statens Serum Institut
Publications - 59
Citations - 3331
Henrik Ravn is an academic researcher from Statens Serum Institut. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 31, co-authored 59 publications receiving 2891 citations. Previous affiliations of Henrik Ravn include Bandim Health Project & Copenhagen University Hospital.
Papers
More filters
Journal ArticleDOI
Randomized Trial of BCG Vaccination at Birth to Low-Birth-Weight Children: Beneficial Nonspecific Effects in the Neonatal Period?
Peter Aaby,Adam Roth,Adam Roth,Henrik Ravn,Bitiguida Mutna Napirna,Amabelia Rodrigues,Ida Maria Lisse,Lone Graff Stensballe,Birgitte Rode Diness,Karen Rokkedal Lausch,Najaaraq Lund,Sofie Biering-Sørensen,Hilton Whittle,Christine Stabell Benn,Christine Stabell Benn +14 more
TL;DR: Though early BCG did not reduce infant mortality significantly, it may have a beneficial effect in the neonatal period, which could be important for public health because BCG is often delayed in low-income countries.
Journal ArticleDOI
Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial
Peter Aaby,Cesario Martins,May-Lill Garly,Carlito Balé,Andreas Andersen,Amabelia Rodrigues,Henrik Ravn,Ida Maria Lisse,Christine Stabell Benn,Hilton Whittle +9 more
TL;DR: The results may indicate that a two dose schedule with Edmonston-Zagreb measles vaccine given at 4.5 and 9 months of age has beneficial non-specific effects on children’s survival, particularly for girls and for children who have not received neonatal vitamin A.
Journal ArticleDOI
Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact.
Sofie Biering-Sørensen,Peter Aaby,Bitiguida Mutna Napirna,Adam Roth,Henrik Ravn,Amabelia Rodrigues,Hilton Whittle,Christine Stabell Benn +7 more
TL;DR: A total of 105 low–birth-weight children presenting for first vaccination were randomized to receive bacillus Calmette-Guérin (BCG) immediately or later (current practice) and administration of BCG vaccine at first contact may contribute to lower mortality.
Journal ArticleDOI
Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections.
Signe Sørup,Christine Stabell Benn,Christine Stabell Benn,Christine Stabell Benn,Anja Poulsen,Tyra Grove Krause,Peter Aaby,Peter Aaby,Henrik Ravn,Henrik Ravn +9 more
TL;DR: In a cohort of Danish children, receipt of live MMR vs inactivated DTaP-IPV-Hib as the most recent vaccine was associated with a lower rate of hospital admissions for any infections.
Journal ArticleDOI
Testing the hypothesis that diphtheria–tetanus–pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries
Peter Aaby,Christine Stabell Benn,Jens Nielsen,Ida Maria Lisse,Amabelia Rodrigues,Henrik Ravn +5 more
TL;DR: These observations are incompatible with DTP merely protecting against the targeted diseases, with herd immunity to whooping cough, DTP is associated with higher mortality for girls and randomised studies of DTP are warranted to measure the true impact on survival.